Description:This patent relates generally to the fields of neurology and the pharmacotherapy of Alzheimer's Disease. More specifically, This patent relates to the novel use of sulfonyl fluorides for the treatment of Alzheimer's Disease.
Abstract:The present invention provides a pharmaceutical composition, comprising a sulfonyl fluoride and a pharmaceutically acceptable carrier. Also provided is a method of treating Alzheimer's disease in an individual in need of such treatment, comprising the step of administering to said individual a therapeutically effective dose of methanesulfonyl fluoride. Further provided is a method of enhancing cognitive performance in an individual in need of such treatment, comprising the step of administering to said individual a therapeutically effective dose of methanesulfonyl fluoride.
Issue Date: 08/25/1998
Application Date: 08/28/1996
Post Date: 03/01/2018
UTEP Docket No: 2000-001GA
